Сравнительное изучение механизмов реализации ишемического повреждения у больных с инфарктом миокарда и с ишемическим атеротромботическим инсультом
Диссертация
Результаты исследования внедрены в практику работы 14 кардиологического отделения и 15 отделения реанимации и интенсивной терапии ГКБ № 1 им. Н. И. Пирогова, кардиологического отделения клиники ФГБУ «Государственного научного центра Российской ФедерацииФедерального медицинского биофизического центра им. А.И. Бурназяна», неврологического отделения для больных с острыми нарушениями мозгового… Читать ещё >
Список литературы
- Аракелян A.A., Бояджян A.A., Погосян A.A., и др. Циркулирующие иммунные комплексы при ишемическом и геморрагическом инсультах. // Журнал неврологии и психиатрии им. С. С. Корсакова. 2003. — № 8. с. 44−47.
- Барбараш O. JL, Зыков М. В., Кашталап В. В., и соавт. Прогностическая ценность различных маркеров воспаления при инфаркте миокарда с подъемом сегмента ST. // Кардиология. 2011. -№ 3. — С. 24−30.
- Берне С.А., Шмидт Е. А., Киприна Е. С. и соавт. Предикторы неблагоприятных коронарных событий у больных острым коронарным синдромом с подъемом сегмента ST, подвергшихся чрезкожным коронарным мвешательствам. // Кардиология. 2010. — № 7. — С. 15−20.
- Берштейн Л.Л., Новиков В. И., Вишневский А. Ю. и соавт. Прогнозирование постинфарктного ремоделирования левого желудочка. // Кардиология. 2011. — № 3. — С. 17−23.
- Васильев С. А., Ефремов Е. Е., Берковский A.JL Плазменный фибронектин патофизиологические аспекты проблемы (дизадгезивность и фибринокомплексная патология), диагностическая и лечебная значимость // Тромбоз, гемостаз и реология. — 2004. — № 3. -С.7−21.
- Гусев Е.И., Скворцова В. И. Ишемия головного мозга. М.: Медицина, 2001. 327 с.
- Драпкина О.М., Ашихмин Я. И., Ивашкин В. Т. Роль шаперонов в патогенезе сердечно-сосудистых заболеваний и кардиопротекции. // Российские медицинские вести. 2008. — № 1. — стр.56−69.
- Еремин И.И. Феномен криоглобулинемии, прогностическая и функциональная значимость криоглобулинов при ишемическом инсульте. Дис. канд. мед. наук. М., 2008. — 120 с.
- Жданов Г. Н., Герасимова М. М. Оценка роли аутоиммунной воспалительной реакции в патогенезе церебральной ишемии // Неврологический вестник. 2003. — Т. 35, № 3−4. — С. 13−17.
- Земсков A.M., Алехина О. Д., Земсков В. М. и соавт. Прогностическое значение типовых иммунных реакций при инфаркте миокарда. // Терапевтический архив. 2008. — № 1. — С. 32−37.
- Ким Л.Б., Путятина А. Н. Динамика биохимических маркеров репаративного фиброза при осложненном течении инфаркта миокарда // Кардиология. 2010. — № 12. — С. 10−14.
- Климов АН, Денисенко АД. О кажущейся и действительной атерогенности иммунных комплексов ЛПНП-IgG в плазме крови и артериальной стенке. // Вестник российской академии медицинских наук. 2007. — № 7. — Стр.3−6.
- Ковальчук Л.В., Хорева М. В., Варивода A.C. Врожденные компоненты иммунитета: То11-подобные рецепторы в норме и при иммунопатологии. // Журнал микробиологии, эпидемиологии и иммунобиологии. 2005. — № 4. — С.96−104.
- Ковальчук Л.В., Хорева М. В., Варивода A.C. и соавт. Роль рецепторов врожденного иммунитета в развитии острого инфаркта миокарда // Журнал микробиологии, эпидемиологии и иммунобиологии. 2008. -№ 4. — С. 64−68.
- Комаров А.Н. Клинико-иммунобиохимическая характеристика криоглобулинемии в патогенезе острого периода ишемического инсульта. Дис. канд. мед.наук. М., 2005.
- Коненков В.И., Шевченко A.B., Прокофьев В. Ф., и соавт. Комплекс генотипов цитокинов как генетический фактор риска развитияинфаркта миокарда у мужчин европеоидного населения России. // Кардиология. 2012. — Т.52, № 7. с. 22−29.
- Константинова H.A. Криоглобулины и патология. М., Медицина. -1999.-216 с.
- Копица Н.П., Белая Н. В., Титаренко Н. В. Роль матриксных металлопротеиназ в патогенезе постинфарктного ремоделирования левого желудочка. // Международный медицинский журнал. 2010. -№ 4. — С.55−58.
- Мирракимов М.М., Китаев М. И., Иманбаев A.C., Маркович М. О. Аутоиммунные реакции на миоглобин у больных с инфарктом миокарда. // Терапевтический архив. 1984. — Т.56, № 10. — С. 53−56.
- Нагорнев В. А. Восканьянц А.Н. Апоптоз и его роль в атерогенезе. // Медицинский академический журнал. 2003. — Т. З, № 4. — С.3−19.
- Нагорнев В. А. Восканьянц А.Н. Атерогенез как иммуновоспалительный процесс // Вестник РАМН. 2004. — в. 7. — С. З-11.
- Оганов Р.Г., Шальнова С. А., Калинина A.M. Профилактика сердечнососудистых заболеваний. М.: ГЭОТ АР-Медиа, 2009. Стр.6−10.
- Пальцев М.А., Иванов A.A., Северин С. Е. Межклеточные взаимодействия. -2-е изд., перераб. и доп. М.: Медицина, 2003. — 288 с.
- Панченко Е.П., Беленков Ю. Н. Характеристика и исходы атеротромбоза у амбулаторных больных в Российской Федерации (по материалам международного регистра REACH). // Кардиология. 2008. — № 2. — С. 17−24.
- Рагино Ю.И., Куимов А. Д., Полонская Я. В. и соавт. Динамика изменений воспалительно-окислительных биомаркеров в крови при остром коронарном синдроме. // Кардиология. 2012. — № 2. — С. 18−22.
- Рагино Ю.И., Чернявская A.M., Полонская Я. В. и соавт. Воспалительно-деструктивные биомаркеры нестабильностиатеросклеротических бляшек: исследования сосудистой стенки и крови. // Кардиология. 2012. — № 5. — С.37−41.
- Реброва О.Ю. Статистический анализ медицинских данных. М., 2003. -С. 213−221.
- Ревматология. Национальное руководство / под. ред. Насонова. М.: ГЭОТАР-Медиа, 2008. — 737 с.
- Рекомендации ВНОК. Диагностика и лечение больных острым инфарктом миокарда с подъемом сегмента ST на ЭКГ. // Кардиоваскулярная терапия и профилактика. 2007. — № 8. — С. 415 500.
- Симбирцев A.C. Цитокины: классификация и биологические функции. // Цитокины и воспаление. 2004. — Т.З. № 2. — стр. 16−22.
- Скворцова В.И., Губский Л. В., Стаховская Л. В. и соавт. Ишемический инсульт. Глава в книге. Неврология: Национальное руководство / под. ред. Е. И. Гусева, А. Н. Коновалова, В. И. Скворцовой, А. Б. Гехт. М.: ГЭОТ АР-Медиа, 2010. — Стр.592−615.
- Скворцова В. И. Насонов Е.Л., Журавлева Е. Ю. и др. Клинико-иммунобиохимический мониторинг факторов локального воспаления всотром периоде полушарного ишемического инсульта. Журнал неврологии и психиатрии. 1999. -№ 5. — С.27−31.
- Скворцова В.И., Шерстнёв В. В., Константинова H.A. и соавт. Участие аутоиммунных механизмов в развитии ишемического повреждения головного мозга // Журнал неврологии и психиатрии. 2005. — Т. 105, № 8.-С. 36−40.
- Скворцова В.И., Шурдумова М. Х., Кольцова Е. А. Особенности атеросклеротического поражения в различных сосудистых бассейнах. // Клиницист. 2008. — № 4. — С. 7−10.
- СПСС (SPSS): искусство обработки информации. Под редакцией Ахим Бююль, Петер Цёфель // Москва, Санкт-Петербург, Киев: ТИД «DiaSoft» 2005. — 602 с.
- Хорева М.В. Комплексный анализ системы То11-подобных рецепторов при различных патологических состояниях человека. Дис. докт. мед. наук. -М., 2012.
- Хорева М.В., Ковальчук JI.B., Варивода A.C. и соавт. Опосредованные через То11-подобные рецепторы выработка цитокинов и экспрессия поверхностных маркеров лейкоцитами человека. // Аллергология и иммунология. 2006. — Т.7, № 2. — С. 199−206.
- Шальнова CA. Эпидемиология сердечно-сосудистых заболеваний и факторы риска в России. Глава в книге. Кардиология: Национальное руководство / под. ред. Ю. Н. Беленкова, Р. Г. Оганова. М.: ГЭОТАР-Медиа, 2010. — Стр.37−51.
- Шахнович P.M. Острый коронарный синдром. Глава в книге. Кардиология: Национальное руководство / под. ред. Ю. Н. Беленкова, Р. Г. Оганова. М.: ГЭОТАР-Медиа, — 2010. — Стр. 665−731.
- Шевченко О.П., Шевченко А. О. Ангиотензин II и инфаркт миокарда. // Рациональная фармакотерапия в кардиологии-2008. № 3. — С. 105−110.
- Шурдумова М.Х. Исследование иммунновоспалительных маркеров развития атеротромботического ишемического инсульта и механизмов реализации ишемического повреждения головного мозга. Дис. канд. мед. наук. М., 2011.
- Юдин А.А., Ковальчук JI.B., Григорьев С. П. и соавт. Анализ активационного апоптоза субпопуляций Т-лимфоцитов периферической крови человека на различных стадиях атерогенеза // Russian Journal of Immunology. 2006. — Vol. 9. Suppl. 3. — P. 76−80.
- Abelleira S., Bevan S., Markus H. Matrix metalloproteinases. // J Med Genet. -2006. V. 43.-P. 897−901.
- Al-Bahrani A., Taha S., Shaath H., et al. TNF-alpha and IL-8 in acute stroke and the modulation of these cytokines by antiplatelet agents. // Curr Neurovasc Res. 2007. — Vol. 4. — P. 31 -37.
- Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. // Stroke. 1993. — V. 24. — P. 35−41.
- Anguera I, Miranda-Guardiola F, Bosch X, et al. Elevation of serum levels of the anti-inflammatory cytokine interleukin-10 and decreased risk of coronary events in patients with unstable angina. // Am Heart J. 2002. — V. 144. — P. 811−817.
- Arslan F., Keogh В., McGuirk P. et al. TLR2 and TLR4 in ischemia reperfusion injury. Mediators of inflammation. 2010. Vol. 2010. Article ID 704 202. doi: 10.1155/2010/704 202.
- Arslan F, Smeets MB, Riem Vis PW et al. Lack of fibronectin-EDA promotes survival and prevents advers remodeling and heart functiondeterioration after myocardial infarction. // Circ Res. 2011. — V. 108, № 5. -P. 582−592.
- Asahi M, Asahi K, Jung JC et al. Role for matrix metalloproteinase9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. // J Cereb Blood Flow Metab. 2000. — V. 20. — P. 1681−1689.
- Asahi M, Wang X, Mori T et al. Effects of matrix met-alloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. // J Neurosci. 2001. — V. 21. — P. 7724−7732.
- Ashida, K., Miyazaki, K., Takayama, E. et al. Characterization of the expression of TLR2 (toll-like receptor 2) and TLR4 on circulating monocytes in coronary artery disease. // J Atheroscler Thromb. 2005. — V. 12.-P. 53−60.
- Ashkenazi A and Dixit VM. Death receptors: signaling and modulation. // Science. 1998. — V. 281. — P. 1305−1308.
- Autret A., Saudeau D., Bertrand Ph. Et al. Stroke risk in patients with carotid stenosis. // Lancet. 1987. — V. 18. — P. 888−890.
- Babaev VR, Porro F, Linton MR F et al. Absence of regulated splicing of fibronectin EDA exon reduces atherosclerosis in mice. // Atherosclerosis. -2008. V.197, № 2. — P. 534−540.
- Barron H.V., Cannon C.P., Murpphy S.A., et al. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction. // Circulation. -2000. V. 102. — P. 2329−2334.
- Basic Kes V., Simundic A.M., Nicolac N., et al. Pro-inflammatory and antiinflammatory cytokines in acute ischemic stroke and their relation to early neurological deficit and stroke outcome. // Clin Biochem. 2008. — V. 41 -P. 1330−1334.
- Bauriedel G., Hutter R., Welsch U. et al. Role of smooth muscle cell death in advanced coronary primary lesions: implications for plaque instability. // Cardiovasc Res. 1999. — V. 41. — P.480−488.
- Berberian PA, Myers W, Tytell M, et al. Immunohistochemical localization of heat shock protein-70 in normal-appearing and atherosclerotic specimens of human arteries. // Am J Pathol. 1990. — V. 136. — P.71−80.
- Bjokbacka H., Kunjathoor V.V., Moore K.J., et al. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways // Nat Med. 2004. — V.10.-P.416−421.
- Blankenberg S., Rupprecht H.J., Poirier O. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. // Circulation. 2003. — V.107. — P. 1579−1585.
- Bobryshev YV, Lord RS. Expression of heat shock protein-70 by dendritic cells in the arterial intima and its potential significance in atherogenesis. // Vase Surg. 2002. — V. 35. — P. 368−375.
- Bonita R, Beaglehole R. Modification of Rankin Scale: Recovery of motor function after Stroke. // Stroke. 1988. — V. 19, № 12. — P. 1497−1500.
- Bowman CC, Rasley A, Tranguch SL, et al. Cultured astrocytes express tolllike receptors for bacterial products. // Glia. 2003. — V. 43. — P. 281−291.
- Boyd J.H., Mathur S., Wang Y., et al. Toll-like receptor stimulation in cardiomyocytes decreases contractility and initiates an NF-kB dependent inflammatory response. // Cardiovascular Research. 2006. — V. 3, № 72. -P. 384−393.
- Brott T.G., Adams H.P. Jr, dinger C.P., et. al. Measurement of acute cerebral infarction: a clinical examination scale. // Stroke. V 1998. — V. 20. — P. 964−970.
- Broughton B, Reutens D, Sobey C. Apoptotic mechanism after cerebral ischemia. // Stroke. 2009. — V. 40. — P.3390−339.
- Brown RD, Jones GM, Laird RE, et al. Cytokines regulate matrix metalloproteinases and migration in cardiac fibroblasts. // Biochem Biophys Res Commun. 2007. — V. 362. — P. 200−205.
- Cadenas, I., Ribo, M., Molina, C.A., et al. Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke. // Stroke. 2006. — V. 37. — P. 1399−1406.
- Cao G, Xiao M, Sun F, et al. Cloning of a novel Apaf-1 -interacting protein: a potent suppressor of apoptosis and ischemic neuronal cell death. // J Neurosci. 2004. — V. 24. — P. 6189−6201.
- Carswell EA, Old LJ, Kassel RL, et al. An endotoxin-induced serum factor that causes necrosis of tumors. // Proc Natl Acad Sci USA. 1975. — V. 72, № 9. — P.3666−3670.
- Caso J.R., Pradillo J.M., Hurtado O. et al. Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. // Circulation. -2007.-V. 115.-P. 1599−1608.
- Castellanos M., Leira R, Serena J, et al. Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke. // Stroke. 2004. — V. 35. — P. 1671−1676.
- Cesari M. Penninx B.W.J.H., Newman A.B. Inflammatory markers and onset of cardiovascular events: results from the Health ABC Study. // Circulation.-2003.-V. 108.-P. 2317−2322.
- Chao W. Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart. // Am J Physiol Heart Circ Physiol. 2009. — V. 296. — P. H1-H12.
- Cho B.B., Toledo-Pereyra L.H. Caspase-independent programmed cell death following ischemic stroke. // J Invest Surg. 2008. — V. 21 — P. 141−147.
- Choi C., Benveniste E. Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses. // Brain Res Rev. 2004. — V. 44, № 1. -P. 65−81.
- Cole J.E., Georgiou E., Monaco C. The expression and functions of toll-like receptors in atherosclerosis. // Mediators Inflamm. 2010. V. 2010: 393 946. doi: 10.1155/2010/393 946.
- Copin, J.C., Merlani P., Sugawara T., et al. Delayed matrix metalloproteinase inhibition reduces intracerebral hemorrhage after embolic stroke in rats. // Exp. Neurol. 2008. — V. 213. — P. 196−201.
- Coussens L.M., Fingleton B., Matrisian L.M. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. // Science. 2002. — V. 295. -P. 2387−2392.
- Cunningham L.A., Wetzel M., Rosenberg G.A. Multiple roles for MMPs and TIMPs in cerebral ischemia. // Glia. 2005. — V. 50. — P.329−339.
- Dalager S., Paaske W.P., Kristensen I.B., et al. Artery-related differences in atherosclerosis expression. Implications for atherogenesis and dynamics in intima-media thickness. // Stroke. 2007. — V. 38, № 8. — P. 2698−2705.
- Doeppner T.R., Nagel F., Dietz G.P. et al. TAT-Hsp70-mediated neuroprotection and increased survival of neuronal precursor cells after focal cerebral ischemia in mice. // Journal of Cerebral Blood Flow & Metabolism. 2009. — V. 29. — P. 1187−1196.
- Dollery CM, Libby P. Atherosclerosis and proteinase activation. // Cardiovasc Res. 2006. — V. 69. — P. 625−635.
- Duncan DJ, Hopkins PM, Harrison SM. Negative inotropic effects of tumour necrosis factor-alpha and interleukin-1 beta are ameliorated by alfentanil in rat ventricular myocytes. // Br J Pharmacol. 2007. — V. 150. -P. 720−726.
- Dybdahl B., Slordahl S.A., Waage A., et al. Myocardial ischemia and the inflammatory response: release of heat shock protein 70 after myocardial infarction. // Heart. 2005. — V. 91. — P. 299−304.
- Edfeldt K., Swedenborg J., Hansson G.K. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. // Circulation. 2002. — V. 105, № 10. — P. l 158−1161.
- Ekdahl C.T., Kokaia Z., Lindvall O. Brain inflammation and adult neurogenesis: the dual role of microglia. // Neuroscience. 2009. — V. 158. -P. 1021−1029.
- Eldrup N., Gronholdt M.L., Sillesen H. Elevated matrix metalloproteinase-9 associated with stroke or cardiovascular death in patients with carotid stenosis. // Circulation. 2006. — V. 114.-P. 1847−1854.
- Elmore S. Apoptosis: a review of programmed cell death. // Toxicol Pathol. -2007.-V. 35.-P. 495−516.
- Emsley H.C., Smith C.J., Tyrrell P.J. Inflammation in acute ischemic stroke and its relevance to stroke critical care. // Neurocrit Care. 2008. — V. 9. -P. 125−138.
- Erickson B., Sperber K., Frishman WH. Toll-like receptors. New Therapeutic targets for the treatment of Atherosclerosis, Acute Coronary Syndromes, and Myocardial Failure. // Cardiol Rev 2008. — V. 16, № 6. -P. 273−279.
- Etoh T, Joffs C, Deschamps AM et al. Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs. // Am J Physiol Heart Circ Physiol. 2001. — V. 281, № 3. — P. H987−994.
- Falk E. Pathogenesis of atherosclerosis. // J Am Coll Cardiol. 2006. — V. 47.-P. 7−12.
- Ferrarese C, Mascarucci P, Zoia C, et al. Increased cytokine release from peripheral blood cells after acute stroke. // J Cereb Blood Flow Metab. -1999.-V. 19. P.1004−1009.
- Ferrari R. Healthy versus sick myocites: metabolism, structure and function. // Eur Heart J. 2002. -№ 4(Suppl G). — P. G1-G12.
- Ferri C., Zignego A.L., Pileri S.A. Cryoglobulins (rewiew). // J Clin Pathol. -2002,-V. 55.-P.4−13.
- Frangogiannis NG. The immune system and cardiac repair. // Pharmacol Res. 2008.-V. 58, № 2. — P.88−111.
- Frangogiannis NG, Mendoza LH, Lindsey ML et al. IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury. // J Immunol. 2000. — V. 165, № 5. — P.2798−2808.
- Frantz S, Bauersachs J, Ertl G. Post-infarct remodeling: contribution of wound healing and inflammation. // Cardiovasc Research. 2009. — № 81.-P. 474−481.
- Frantz S., Ertl G., Bauersachs J. Mechanisms of disease: Toll-like receptors in cardiovascular disease. // Nat Clin Pract Cardiovasc Med. 2007. — V. 4, № 8. — P.444−454.
- Galis Z.S., Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. // Circ Res. 2002. — V. 90. -P. 251−262.
- Galis Z.S., Sukhova G.K., Lark M.W. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. // J Clin Invest.-1994.-V. 94 P. 24 932 503.
- Gasche Y, Soccal PM, Kanemitsu M. Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain.//Front Biosci. 2006. — V. 11.-P. 1289−1301.
- Geng Y.J., Henderson L.E., Levesque E.B. et al. Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cell. // Arterioscler Thromb Vase Biol. 1997. — V. 17.-P. 2200−2208.
- Giffard RG, Xu L, Zhao H, et al. Chaperones, protein aggregation, and brain protection from hypoxic/ischemic injury. // J Exp Biol. 2004. — V. 207. -P. 3213−3220.
- Giffard RG, Yenari MA. Many mechanisms for hsp70 protection from cerebral ischemia. J Neurosurg Anesthesiol 2004. — V. 16, № 1. — 53−61.
- Ginsberg MD. Adventure in pathophysiology of brain ischemia: penubra, gene expression, neuroprotection. The Thomas Willis lecture. // Stroke. -2003.-V. 34, № l.-P. 214−223.
- Gromadzka G, Zielinska J, Ryglewicz D, et al. Elevated levels of anti-heat shock protein antibodies in patients with cerebral ischemia. // Cerebrovasc Dis. 2001. — V. 12, № 3.- P. 235−239.
- Gu Z, Kaul M, Yan B, et al. S-nitrosylation of matrix metalloproteinases: Signaling pathway to neuronal cell death. // Science. 2002. — V. 297. — P. 1186−1190.
- Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. // Cerebrovasc Dis. 2008. — V. 25 № 5. — P. 457−507.
- Guo, R.W., Yang, L.X., Wang, H., et al. Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappaB- dependentpathway in vascular smooth muscle cells. // Regul. Pept. 2008. — V. 147. -P. 37−44.
- Hansson G.K., Libby P. The immune response in atherosclerosis: a double-edged sword. // Nat Rev Immunol. 2006. — V. 6. — P. 508−519.
- Hartl F.U., Hayer-Hartl M. Molecular chaperones in the cytosol: from nascent chain to folder protein. // Science. 2002. — V. 295. — P. 1852−1858.
- Henderson B., Pockley A.G. Molecular chaperones and protein-folding catalysts as intercellular signaling regulators in immunity and inflammation. // J Leukoc Biol. 2010. — V. 88, № 3. — P. 445−462.
- Hightower L.E., Guidon P.T. Selective release from cultured mammalian cells of heat-shock (stress) proteins that resemble glia-axon transfer proteins. //J Cell Physiol. 1989,-V. 138.-P. 257−266.
- Holler N., Zaru R., Micheau 0., et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. // Nat. Immunol. 2000. — V. 1. — P. 489−495.
- Horstmann S., Kalb P., Koziol J., et al. Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: Influence of different therapies. // Stroke. 2003. — V. 34. — P. 2165−2170.
- Hosomi N., Nishiyama A., Ban C.R., et al. Angiotensin type 1 receptor blockage improves ischemic injury following transient focal cerebral ischemia. // Neuroscience. 2005. — V. 134. — P.225−231.
- Hua F., Ma J., Ha T., et al. Differential roles of TLR2 and TLR4 in acute focal cerebral ischemia/reperfusion injury in mice. // Brain Res. 2009. — V. 1262.-P. 100−108.
- Hunter-Lavin C., Davies E.L., Bacelar M., et al. Hsp70 release from peripheral blood mononuclear cells. // Biochemical and biophysical research communications. -2004. V. 324.-P. 511−517.
- Iadecola C., Antrather J. The immunology of stroke: from mechanisms to translation. // Nat Med. 2011. — V. 17, № 7. — P. 796−808.
- Irwin M.W., MaK S., Mann D.L., et al. Tissue expression and immunolocalization of tumor necrosis factor-a in postinfarction dysfunctional myocardium. // Circulation. 1999. — V. 99. — P. 1492−1498.
- Ishikawa Y, Satoh M, Itoh T et al. Local expression of Toll-like receptor 4 at the site of ruptured plaques in patients with acute myocardial infarction. // Clin Sci (Lond). 2008. — V. 115, № 4. — P. 133−140.
- Jack C.S., Arbour N., Manusow J. et al. TLR signaling tailors innate immune responses in human microglia and astrocytes. // J Immunol. 2005. — V. 175, № 7. — P. 4320−4330.
- Jan M., Meng S., Chen N.C. et al. Inflammatory and autoimmune reaction in atherosclerosis and vaccine design informatics. // J Biomed Biotechnol. -2010. vol. 2010. Article ID 459 798, 16 pages, doi: 10.1155/2010/459 798.
- Jansen J. The microscopic transitional zone between elastic and muscular arteries. // Arch Mai Coeur Vaiss. 2004. — № 97. — P. 909−914.
- Jefferis B.J., Whincup P.H., Welsh P., et al. Circulating TNF levels in older men and women do not show independent prospective relations with MI or stroke. // Atherosclerosis. 2009. — V. 205, № 1. — P. 302−308.
- Jeremias I., Kupatt C., Martin-Villalba A, et al. Involvement of CD95/Apol/Fas in cell death after myocardial ischemia. // Circulation. -2000.-V. 102.-P. 915−920.
- Jin R., Yang G., Li G. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. // J Leukoc Biol. 2010. — V. 87. — P. 779−789.
- Jin X., Xiao C., Tancuay R.M. et al. Correlation of lymphocyte heat shock protein 70 levels with neurologic deficits in elderly patients with cerebral infarction. // Am J Med. 2004. — V. 117, № 6. — P. 406−411.
- Johnson C., Galis Z.S. Matrix metalloproteinase-2 and -9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization. // Arterioscler Thromb Vase Biol. 2004. — V. 24. — P. 54−60.
- Joly A.L., Wettstein G., Mignot G. et al. Dual role of heat shock proteins as regulators of apoptosis and innate immunity. // J Innate Immun. 2010. — V. 2.-P. 238−247.
- Kaczorowski D.J., Nakao A., Mollen KP. et al. Toll-like receptors 4 mediates the early inflammatory response after cold ischemia/reperfusion. // Transplantation. 2007. — V. 84, № 10. — P. 1279−1287.
- Kajstura J., Cheng W., Reiss K., et al. Apoptotic and necrotic myocyte cell deaths arc independent contributing variables of infarct size in rats. // Lab Invest. 1996. — V. 74, № 1. — P. 86−107.
- Kalil A.C., LaRosa S.P., Gogate J., et al. Influence of severity of illness on the effects of eritoran tetrasodium (E5564) and on other therapies for severe sepsis. // Shock. 2011. — V. 36, № 4. — P. 327−331.
- Kameda K., Matsunaga T., Abe N., et al. Increased pericardial fluid level of matrix metalloproteinase-9 activity in patients with acute myocardial infarction: possible role in the development of cardiac rupture. // Circ J. -2006.-V. 70.-P. 673−678.
- Kamel H., Iadecola C. Brain-immune interactions and ischemic stroke: clinical implications. // Arch Neurol. 2012. — V. 69, № 5. — P. 576−581.
- Kannel W.B., Wolf P.A. Peripheral and cerebral atherothrombosis and cardiovascular events in different vascular territories: insights from the Framingham Study. // Curr Atheroscler Rep. 2006. — V. 8. — P. 317−323.
- Kaplan R.C. Smith N.L. Zucker S. Matrix metalloproteinase-3 (MMP3) and MMP9 genes and risk of myocardial infarction, ischemic stroke, and hemorrhagic stroke. // Atherosclerosis. 2008. — V. 201. — P. 130−137.
- Kelly S., Zhang Z.J., Zhao H., et al. Gene transfer of HSP72 protects cornu ammonis 1 region of the hippocampus neurons from global ischemia: influence of Bcl-2. // Ann Neurol. 2002. — V. 52. — P. 160−167.
- Kiechl S., Lorenz E., Reindl M., et al. Toll-like receptor 4 polymorphisms and atherogenesis. // N Engl J Med. 2002. — V. 347. — P. 185−192.
- Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II -mediated cardiovascular and renal diseases. // Pharmacol Rev. 2000. — V. 52.-P. 11−34.
- Kjellstrom T., Norrving B., Shatchkute A. Helsingborg declaration 2006 on European stroke strategies. // Cerebrovasc Dis. 2007 — V. 23. — P. 231 241.
- Kleemann R. Zadelaar S. Kooistra T. Cytokines and atherosclerosis: a comprehensive review of studies in mice. // Cardiovasc Res. 2008. — V. 79.-P. 360−376.
- Koh S.H., Chang D.I., Kim H.T., et al. Effect of 3-aminobenzamide, parp inhibitor, on matrix metalloproteinase-9 level in plasma and brain of ischemic stroke model. // Toxicology. 2005. — V. 214. — P. 131−139.
- Kolodgie F.D., Narula J., Burke A.P., et al. Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death. // Am J Pathol. -2000. V. 157.-P. 1259−1268.
- Krishnamurthy P., Rajasingh J., Lambers E., et al. IL-10 Inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. // Circ Res. -2009, — V. 104.-P. e9-el8.
- Krupinski J., Lopez E., Marti E. Expression of caspases and their substrates in the rat model of focal cerebral ischemia. // Neurobiol Dis. 2000. — V. 7. -P. 332−342.
- Kubota T., Miyagishima M., Frye C.S., et al. Overexpression of tumor necrosis factor-alpha activates both anti- and pro-apoptotic pathways in the myocardium. // J Mol Cell Cardiol. 2001. — V. 33. — P. 1331−1344.
- Labrum R., Bevan R., Sitzer M. Toll receptor polymorphisms and carotid artery intima-media thickness. // Stroke. 2007. — V. 38. — P. 1179−1184.
- Lambertsen K.L., Biber K., Finsen B. Inflammatory cytokines in experimental and human stroke. // J Cereb Blood Flow Metab. 2012. — V. 32, № 9.-P. 1677−1698.
- Lasky LA. Selectins: interpreters of cell-specific carbohydrate information during inflammation. // Science. 2000. — P. 964−969.
- Latchman D.S. Heat shock proteins and cardiac protection. // Cardiovasc Res.-2001.-V. 51.-P. 637−646.
- Lee J.E., Kim Y.J., Kim J.Y., et al. The 70kDa heat shock protein suppresses matrix metalloproteinases in astrocytes. // Neuroreport. 2004. — V. 15. — P. 499−502.
- Lee P., Sata M., Lefer D.J., et al. Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo. // Am J Physiol Heart Circ Physiol. 2003. — V. 284. — P. 456−463.
- Lee S.H., Kim M., Yoon B.W., et al. Targeted hsp70.1 disruption increases infarction volume after focal cerebral ischemia in mice. // Stroke. 2001. -V. 32.-P. 2905−2912 .
- Lee S.R., Kim H.Y., Rogowska J., et al. Involvement of matrix metalloproteinase in neuroblast cell migration from the subventricular zone after stroke. // J. Neurosci. 2006. — V. 26. — P. 3491−3495.
- Lee S.R., Lo E.H. Induction of caspase-mediated cell death by matrix metalloproteinases in cerebral endothelial cells after hypoxia-reoxygen-ation. // J Cereb Blood Flow Metab. 2004. — V. 24. — P. 720−727.
- Lee Y., Gustafsson A.B. Role of apoptosis in cardiovascular disease. // Apoptosis. 2009. — V. 14, № 4. — P. 536−548.
- Lehnardt S., Lachance C., Patrizi S., et al. The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CN. // J Neurosci. 2002. — V. 22. — P. 2478−2486.
- Lehtimaki T, Lehtinen S, Solakivi T et al: Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease. // Arterioscler Thromb Vase Biol. 1999. — V. 19. — P. 2327.
- Leist M., Single B., Castoldi A.F., et al. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis.//J Exp Med. 1997.-V. 185.-P. 1481−1486.
- Lerner A.B., Watson C.J. Studies of cryoglobulins. Unusual purpura associated with the presence of a high concentration of cryoglobulin (cold precipitable serum globulin). // Am J Med Sci. 1947.- V. 214. — P. 410 415.
- Levine S.J. Molecular mechanisms of soluble cytokine receptor generation. //J Biol Chem. 2008. — V. 283, № 21. — P. 14 177−14 181.
- Li Y., Takemura G., Kosai K., et al. Critical roles for the Fas/Fas ligand system in postinfarction ventricular remodeling and heart failure. // Circ Res. -2004,-V. 95.-P. 627−636.
- Libby P., Ridker P.M., Hansson G.K. Inflammation in atherosclerosis: from pathophysiology to practice. // J Am Coll Cardiol. 2009. — V. 54, № 23. -P. 2129−2138.
- Liebetrau M., Burggraf D., Wunderlich N., et al. ACE inhibition reduces activity of the plas-minogen/plasmin and MMP systems in the brain of spontaneous hypertensive stroke-prone rats. // Neurosci. Lett., 2005. — V. 376.-P. 205−209.
- Liew F.Y., Brint E.K. Negative regulation of Toll-like receptor- mediated immune responses // Nature. 2005. — Vol. 5, № 6. — P. 446−458.
- Lin Y.C., Chang Y.M., Yu J.M., et al. Toll-like receptor 4 gene CI 19A but not Asp299Gly polymorphism is associated with ischemic stroke among ethnic Chinese in Taiwan. // Atherosclerosis. 2005. — V. 180. — P. 305−309.
- Lindmark E., Wallentin L., Siegbahn A. Blood cell activation, coagulation, and inflammation in men and women with coronary artery disease. // Thromb Res. 2001. — V. 103. — P. 249−259.
- Littlewood T.D., Bennett M.R. Apoptotic cell death in atherosclerosis. // Curr Opin Lipidol. 2003. — V. 14. — P. 469−475.
- Liu T., Clark R.K., McDonnell P.C., et al. Tumor necrosis factor-alpha expression in ischemic neurons. // Stroke. 1994. — V. 25. — P. 1481−1488.
- Liu X.S., Chopp M., Zhang R.L. Angiopoietin 2 mediates the differentiation and migration of neural progenitor cells in the subventricular zone after stroke. // J Biol Chem. 2009. — V. 284, № 34. — P. 22 680−22 689.
- Lopez A.D., Mathers C.D., Ezzati M., et al. Global and regional burden of disease and risk factors: Systematic analysis of population health data. // Lancet. 2006. — V. 367. -P. 1747−1757.
- Lome E., Dupont H., Abraham E. Toll-like receptors 2 and 4: initiators of non-septic inflammation in critical care medicine? // Intensive Care Med. -2010.-V. 36 (11).-P. 1826−1835.
- Lu L., Gunja-Smith Z., Woessner J.F. et al. Matrix metalloproteinases and collagen ultrastructure in moderate myocardial ischemia and reperfusion in vivo. // Am J Physiol Heart Circ Physiol. 2000. — V. 279. — P. H601−609.
- Luan Z., Chase A.J., Newby A.C. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages. // Arterioscler Thromb Vas Biol. 2003. — V. 23. — P. 769 775.
- Luss H., Schafers M., Neumann J., et al. Biochemical mechanisms of hibernation and stunning in the human heart. // Cardiovascular Research. -2002.-V. 56.-P. 411−421.
- Macario A., Conway de Macario E. Sick chaperones, cellular stress, and disease.//N Engl J Med.-2005,-V. 353.-P. 1489−1501.
- MacEwan DJ. TNF receptor subtype signaling: differences and cellular consequences. // Cell Signal. 2002. — V. 14: — P. 477−492.
- Magnusson M.K., Mosher D.F. Fibronectin: structure, assembly, and cardiovascular implications. // Arterioscler Tromb Vase Biol. 1998. — V. 18.-P. 1363−70.
- Mallat Z., Besnard S., Duriez M., et al. Protective role of interleukin-10 in atherosclerosis. // Circ Res. 1999. — V. 85. — P. el7-e24.
- Mambula S.S., Stevenson M.A., Ogawa K. Mechanisms for Hsp70 secretion: crossing membranes without a leader. // Methods. 2007 — V. 43 № 3. — P. 168−75.
- Management of acute myocardial infarction in patients with persistent ST-segment elevation. Esc Guidelines. // Eur Heart J. 2008. — V. 29. — P. 2909−2945.
- Mandal K., Jahangiri M., Xu Q. Autoimmunity to heat shock proteins in atherosclerosis. // Autoimmunity reviews. 2004. — V. 3. — P. 31−37.
- Mann D.L. Stress-activated cytokines and the heart: from adaptation to maladaptation. // Ann Rev Physiol. 2003. — V. 65. — P. 81−101.
- Martin-Villalba A., Hahne M., Kleber S. et al. Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke. // Cell Death Differ. 2001. — V. 8. — P. 679−668.
- Martin-Villalba A., Herr I., Jeremias I., et al. CD95 ligand (Fas-L/APO-lL) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. // J Neurosci. 1999. — V. 19. — P. 38 093 817.
- Marx N., Neumann F.J., Ott I., et al. Induction of cytokine expression in leukocytes in acute myocardial infarction. // J Am Coll Cardiol. 1997. — V. 30.-P. 165−170.
- McCully J., Wakiyama H., Hsieh Y-J., et al. Differential contribution of necrosis and apoptosis in myocardial ischemia-reperfusion injury. // Am J Physiol Heart Circ Physiol. — 2004. — V. 286. — P. H1923-H1935.
- Methe H., Kim J.O., Kofler S. et al. Expansion of circulating toll-like receptor 4-positive monocytes in patients with acute coronary syndrome. // Circulation. 2005. — V. 111. — P. 2654−2661.
- Monden Y., Kubota T., Tsutsumi T., et al. Soluble TNF receptors prevent apoptosis in infiltrating cells and promote ventricular rupture and remodeling after myocardial infarction. // Cardiovascular Research. 2007.- V.73.-P. 794−805.
- Montaner J., Alvarez-Sabin J., Molina C.A., et al. Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke. // Stroke. 2001. — V. 32. — P. 2762−2767.
- Montaner J., Molina C.A., Monasterio J., et al. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. // Circulation. 2003. — V. 107. — P. 598−603.
- Montaner J., Rovira A., Molina C.A., et al. Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted imagelesions in hyperacute stroke. // J Cereb Blood Flow Metab. 2003. — V. 23. -P. 1403−1407.
- Montesinos M.C., Desai A., Chen J.F., et al. Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A (2A) receptors. Am J Pathol. 2002. — V. 160 (6). — P.2009−2018.
- Moore K.W., de Waal Malefyt R., Coffman R.L. Interleukin-10 and the interleukin-10 receptor. // Annu Rev Immunol. 2001. — V. 19. — P. 683 765.
- Murakami Y., Saito K., Hara A., et al. Increases in tumor necrosis factor-alpha following transient global cerebral ischemia do not contribute to neuron death in mouse hippocampus. // J Neurochem. 2005 — V. 6. — P. 1616−1622.
- Murphy G., Nagase H. Progress in matrix metalloproteinase research. // Mol. Aspects Med. 2008. — V. 29. — P. 290−308.
- Mustafa A., Nityanand S., Berglund L., et al. Circulating immune complexes in 50-year-old men as a strong and independent risk factor for myocardial infarction. // Circulation. 2000. — V. 102. — P. 2576−2581.
- Nagase H., Visse R., Murphy G. Structure and function of matrix metalloproteinases and TIMPs. // Cardiovasc Res. 2006. — V. 69. — P. 562 573.
- Naghavi M., Libby P., Falk E., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. // Circulation. 2003. — № 108. — P. 1664−1672.
- Nakajima H., Yanase N., Oshima K., et al. Enhanced expres°sion of apoptosis inducing ligand TRAIL in mononuclear cells after myocardial infarction. // Jpn Heart J. 2003. — V. 44. — P. 833−844.
- Nayak A.R., Kashyap R.S., Purohit H.J., et al. Evaluation of the inflammatory response in sera from acute ischemic stroke patients by measurement of IL-2 and IL-10. // Inflamm Res. 2009. — V. 58. — P. 687 691.
- Newby A.C. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. // Physiol Rev. 2005. — V. 85.-P. 1−31.
- Newby A.C. Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability. // Arterioscler Thromb Vase Biol. 2008. — V. 28. — P. 2108−2114.
- Nian M., Lee P., Khaper N. Inflammatory cytokines and postmyocardial infarction remodeling. // Circ Res. 2004. — V. 94. — P. 1543−1553.
- Ohtsuka T., Hamada M., Sasaki O., et al. Clinical implications of circulating soluble Fas and Fas ligand in patients with acute myocardial infarction. // Coronary Artery Disease. 1999. — V. 10. — P. 221−225.
- Okada M., Hasebe N., Aizawa Y. et al. Thermal treatment attenuates neointimal thickening with enhanced expression of heat-shock protein 72 and suppression of oxidative stress. // Circulation. 2004. — V. 109. — P. 1763−1768.
- Olivetti G., Quaini F., Sala R., et al. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. // J Moll Cell Cardiol. 1996. — V. 28. — P. 2005−2016.
- Ono K., Matsumori A., Shioi T., et al. Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. // Circulation. 1998. — V. 98. — P. 149−156.
- Ooboshi H, Ibayashi S, Shichita T et al. Postischemic gene transfer of interleukin-10 protects against both focal and global brain ischemia. // Circulation. 2005. — V. 111, № 7. — P. 913−919.
- Oto J., Suzue A., Inui D. et al. Plasma proinflammatory and antiinflammatory cytokine and catecholamine concentrations as predictors of neurological outcome in acute stroke patients. // J Anesth. 2008. — V. 22, № 3. — P. 207−212.
- Oyama J., Blais Jr C., Liu X., et al. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. // Circulation. -2004.-V. 109.-P. 784−789.
- Park K.P., Rossel A., Foerch C. et al. Plasma and brain matrix metalloproteinase-9 after acute focal cerebral ischemia in rats. // Stroke. -2009. V. 40, № 8. — P. 2836−2842.
- Peeters W., Hellings W.E., de Kleijn D.P.V., et al. Carotid atherosclerotic plaques stabilize after stroke insights into the natural process of atherosclerotic plaque stabilization. // Arterioscler Thromb Vase Biol. -2009. № 29. — P. 128−133.
- Pelidou S.H., Kostulas N., Matusevicius D., et al. High levels of IL-10 secreting cells are present in blood in cerebrovascular diseases. // Eur J Neurol. 1999. — V. 6. — P. 437−442.
- Peng J., Gurantz D., Tran V., et al. Tumor necrosis factor-alpha-induced ATI receptor upregulation enhances angiotensin II-mediated cardiac fibroblast responses that favor fibrosis. // Circ Res. 2002. — V. 91. — P. 1119−1126.
- Perini F., Morra M., Alecci M., et al. Temporal profile of serum antiinflammatory and pro-inflammatory interleukins in acute ischemic stroke patients. // Neurol Sci. 2001. — V. 22. — P. 289−296.
- Peterson J.T., Li H., Dillon L., et al. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat. // Cardiovasc Res. 2000. — V. 46, № 2. — P. 307−315.
- Pinderski Oslund L.J., Hedrick C.C., Olvera T., et al. Interleukin 10 blocks atherosclerotic events in vitro and in vivo. // Arterioscler Thromb Vase Biol.- 1999. V. 119. — P. 2847−2853.
- Pinhal-Enfield G., Ramanathan M., Hasko G., et al. An angiogenic switch in macrophages involving synergy between toll-like receptors 2,4,7, and 9 and adenosine A2A receptors. // Am J Pathol. 2003. — V. 163. — P. 711−721.
- Piro F.R., di Gioia CRT, Gallo P., et al. Is apoptosis a diagnostic marker of acute myocardial infarction? // Arch Pathol Lab Med. 2000. — V. 124. — P. 827−831.
- Planas A.M., Sole S., Justicia C. Expression and activation of matrix metalloproteinase-2 and-9 in rat brain after transient focal cerebral ischemia. // Neurobiol Dis. 2001. — V. 8. — P. 834−846.
- Pockley A.G., Georgiades A., Thulin T., et al. Serum heat shock protein 70 levels predict the development of atherosclerosis in subjects with established hypertension. // Hypertension. 2003. — V. 42. — P. 235−238.
- Pockley A.G., Shepherd J., Corton J.M., Detection of heat shock protein 70 (Hsp70) and anti-Hsp70 antibodies in the serum of normal individuals. // Immunol. Invest. 1998. — V. 27. — P. 367−377.
- Popp A., Jaenisch N., Witte O. Identification of ischemic regions in rat model of stroke. // Plos ONE. 2009. — V. 4, № 3. — P. E4764.
- Pradillo J.M., Romera C., Hurtado O., et al. TNFR1 upregulation mediates tolerance after brain ischemic preconditioning. // J Cereb Blood Flow Metab.- 2005. V. 25, № 2. — P. 193−203.
- Rajdev S., Hara K., Kokubo Y., et al. Mice overexpressing rat heat shock protein 70 are protected against cerebral infarction. // Ann Neurol. 2000. -V. 47.-P. 782−791.
- Redgrave J.N., Lovett J.K., Gallagher P.J. Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study. // Circulation. 2006. — № 113. — P. 2320−2328.
- Riad A., Jager S., Sobirey M. et al. Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice. J Immunol. 2008. — V. 180. — P. 6954−6961.
- Ritossa F. A new puffing pattern induced and temperature shock and DNP in Drosophilia. // Experimentia. 1962. — V. 18.-P. 571−573.
- Romanic A.M., Burns-Kurtis C.L., Gout B., et al. Matrix metalloproteinase expression in cardiac myocytes following myocardial infarction in the rabbit.//Life Sci. -2001. V. 68, № 7.-P. 799−814.
- Romanic A.M., White R.F., Arleth A.J., et al. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: Inhibition of matrix metalloproteinase-9 reduces infarct size. // Stroke. 1998. — V. 29. -1020−1030.
- Rosell A., Ortega-Aznar A., Alvarez-Sabin J., et al. Increased brain expression of Matrix Metalloproteinase-9 after ischemic and hemorrhagic human stroke. // Stroke. 2006- - V. 37: — 1399−1406.
- Rosenbaum DM, Gupta G, D’Amore J, et al. Fas (CD95/APO-1) plays a role in the pathophysiology of focal cerebral ischemia. // J Neurosci Res. 2000. -V. 61.-P. 686−692.
- Rosenberg, G.A. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. // Lancet Neurol. 2009. — V. 8, — P. 205−216.
- Sadeghi M.M., Glover D.K., Lanza G.M., et al. Imaging atherosclerosis and vulnerable plaque.//J Nucl Med. 2010 — V. 51 Suppl 1. — P. 51S-65S.
- Sadoshima J. Cytokine actions of angiotensin II. // Circ Res 2000. — V. 86. -P. 1187−1189.
- Saraste A., Pulkki K., Kallajoki M., et al. Apoptosis in human acute myocardial infarction. // Circulation. 1997. — V. 95. — P. 320−323.
- Satoh M., Shimoda Y., Maesawa C. et al. Activated toll-like receptor 4 in monocytes is associated with heart failure after acute myocardial infarction. // Int J Cardiol. 2006. — V. 10. — P. 226−234.
- Satoi S., Hiramatsu Y., Kitade H., et al. Different responses to surgical stress between extra domain A and plasma fibronectins. // Clinical and Exp Pharm and Physiol. 1999. — V. 26. — P. 225−229.
- Seljeflot I., Hurlen M., Solheim S., et al. Serum levels of interleukin 10 are inversely related to future events in patients with acute myocardial infarction. // J Thromb Haemost. 2004. — V. 2. — P. 350−352.
- Sha T., Iizawa Y., Ii M. Combination of imipenem and TAK-242, a Toll-like receptor-4 signal transduction inhibitor, improves survival in a murine model of polymicrobial sepsis. // Shock. 2011. — V. 35, № 2. — P. 205−209.
- Shimizu ML, Fukuo K., Nagata S., et al. Increased plasma levels of the soluble form of Fas ligand in patients with acute myocardial infarction and unstable angina pectoris. // J Am Coll Cardiol. 2002. — V. 39. — P. 585 590.
- Simpson A.W., Bcughton B.J. Fibronectin as an opsonic regulator of monocyte phagocytosis. // J.Clin.Pathol. 1984 — V. 37. — P. 787−789.
- Siwik D.A., Colucci W.S. Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium. // Heart Failure Rev. 2004. — V. 9. — P. 43−51.
- Sobesky J., Zaro O Weber, Lehnhardt F.-G., et al. Does the Mismatch Match the Penumbra?: Magnetic resonance imaging and positron emission tomography in early ischemic stroke. // Stroke. 2005. — V.36. — P.980−985.
- Song J.H., Bellail A., Tse M.C. et al. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. // J Neurosci. 2006. — V. 22, № 12. — P. 3299−3308.
- Spera P.A., Ellison J.A., Feuerstein G.Z. IL-10 reduces rat brain injury following focal stroke. //Neurosci Lett. 1998,-V. 251. — P. 189−192.
- Spinale F.G. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. // Physiol Rev. -2007.-V. 87.-P. 1285−1342.
- Sukhija R., Fahdi I., Garza L. Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome. Am J Cardiol. 2007. — V. 99.-P. 879−884.
- Sundstrom J., Evans J.C., Benjamin E.J., et al. Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographicmeasures: the Framingham Heart Study. // Eur Heart J. 2004. — V. 25. — P. 1509−1516.
- Suzuki K., Sawa Y., Kagisaki K., et al. Reduction in myocardial apoptosis associated with overex-pression of heat shock protein 70. // Basic Res Cardiol. 2000. — V. 95. — P. 397−403.
- Suzuki Y. Role of tissue-type plasminogen activator in ischemic stroke. // J Pharmacol Sci. 2010. — V. 113. — P. 203−207.
- Suzuki Y., Nagai N., Umemura K. et al. Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in mice. // J Thromb Haemost. 2007. — V. 5. — P. 1732−1739.
- Szczepanska-Szerej A., Kurzepa J., Wojczal L. Simvostatin-induced prevention of the increase in TNF-alfa level in the acute phase of ischemic stroke. // Pharmacological Reports. 2007. — V. 59. — P. 94−97.
- Takeda K., Akira S. Toll-like receptors in innate immunity. // International Immunology. 2005. — V. 17, № 1. — P. 1 -14.
- Tanaka H., Takai S., Jin D., et al. Inhibition of matrix metalloproteinase-9 activity by trandolapril after middle cerebral artery occlusion in rats. // Hypertens. Res. 2007. — V. 30. — P. 469−475.
- Tang S.-C., Arumugam T.V., Xu X., et al. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. // Proc of the Natl Acad Sci USA.- 2007. V. 104, № 34. — P. 13 798−13 803.
- Tarkowski E., Rosengren L., Blomstrand C., et al. Intrathecal release of pro-and anti-inflammatory cytokines during stroke. // Clin Exp Immunol 1997. -V. 61, № 110.-P. 492−499.
- Tarnacka B., Gromadzka G., Czlonkowska A. Increased Circulating immune complexes in acute stroke. Stroke. 2002. — V. 33. — P. 936−940.
- Taylor R.C., Cullen S.P., Martin S.J. Apoptosis: controlled demolition at the cellular level. // Nat Rev Mol Cell Biol. 2008. — V. 9. — P. 231 -241.
- Terry DF., McCormick M., Andersen S, et al. Cardiovascular disease delay in centenarian offspring. Ann. N.Y. Acad. Sci. 2004. — V. 1019. — P. 502 505.
- Terry D.F., Wilcox M.A., McCormick M.A. Cardiovascular disease delay in centenarian offspring. // J Gerontol A Biol Sci Med Sci. 2004. — V. 59, № 4.-P. 385−389.
- The European Stroke Initiative Executive Committee and the EUSI Writing Committee: European stroke initiative recommendations for stroke management update 2003. // Cerebrovasc Dis.-2003. — V. 16. — P. 311 337.
- Theriault J.R., Mambula S.S., Sawamura T., et al. Extracellular HSP70 binding to surface receptors present on antigen presenting cells and endothelial/epithelial cells. // FEBS Lett. 2005. — V. 579. — P. 1951−1960.
- Timmers L., Sluijter J.P.G., van Keulen J.K. et al. Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. // Circ Res. 2008. — V. 102. — P. 257 264.
- Tissieres A., Mitchell H.K., Tracy U.M. Protein synthesis in salivary glands of Drosophila melanogaster. // J. Mol. Biol. 1974. — V. 84. — P. 389−398.
- Tsuchiya D., Hong S., Matsumori Y., et al. Overexpression of rat heat shock protein 70 reduces neuronal injury after transient focal ischemia, transient global ischemia, or kainic acid-induced seizures. // Neurosurgery. 2003. -V. 53.-P. 1179−1188.
- Tyagi S.C., Campbell S.E., Reddy H.K., et al. Matrix metalloproteinase activity expression in infarcted, noninfarcted and dilated cardiomyopathic human hearts.//Mol Cell Biochem. 1996. — V. 155.-P. 13−21.
- Tytell M., Greenberg S.G., Lasek R.J. Heat shock-like protein is transferred from glia to axon. // Brain Res. 1986. — V. 363 — // P. 161−164.
- Vila N., Castillo J., Davalos A., et al. Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke. // Stroke. 2003. — V. 34.-P. 671−675.
- Vila N., Castillo J., Davalos A. et al. Proinflammatory cytokines and early neurological worsening in ischemic stroke. // Stroke. 2000. — V. 31. — P. 2325−2329.
- Vogt M., Bauer M.K., Ferrari D. Oxidative stress and hypoxia/reoxygenation trigger CD95 (APO-l/Fas) ligand expression in microglial cells. // FEBS Lett. 1998. — V. 429, № 1. — P. 67−72.
- Wang Q., Tang X.N., Yenari M.A. The inflammatory response in stroke. // J Neuroimmunol. 2007. — V. 184, № 1−2. — P. 53−68.
- Webb C.S., Bonnema D.D., Ahmed S.H., et al. Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling. // Circulation. 2006. — V. 114.-P. 1020−1027.
- Weinstein P.R., Hong S., Sharp F.R. Molecular identification of the ischemic penumbra. // Stroke. 2004. — V. 35. — P. 2666−2670.
- Welsh P., Lowe G.D., Chalmers J. Associations of proinflammatory cytokines with the risk of recurrent stroke. // Stroke. 2008. — V. 39. — P. 2226−2230.
- Welsh P., Whincup P.H., Papacosta O. Serum matrix metalloproteinase-9 and coronary heart disease: a prospective study in middle-aged men. // QJM. -2008,-V. 101.-P. 785−791.
- White E.S., Baralle F.E., Muro A.F. New insights into form and function of fibronectin splice variants. // J Pathol. 2008. — V. 216. — P. 1−14.
- Wick G., Knoflach M., Xu Q. Autoimmune and inflammatory mechanisms in atherosclerosis. // Annu Rev Immunol. 2004. — V. 22. — P. 361−403.
- Wolf-Dieter Heiss, Sobesky J., Hesselmann V. Identifying thresholds for penumbra and irreversible tissue damage. // Stroke. 2004. — V. 35. — P. 2671 -2674.
- Xia Y., Yamagata K., Krukoff T.L. Differential expression of the CD14/TLR4 complex and inflammatory signaling molecules following i.e.v. administration of LPS. // Brain Research. 2006. — V. 1095, № 1. — P. 8595.
- Xu Q. Role of heat shock proteins in atherosclerosis. // Arterioscler Thromb Vase Biol. 2002. — V. 22. — P. 1547−1559.
- Xu Q., Schett G., Perschinka H. et al. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. // Circulation. 2000. — V. 102, № 1. — P. 14−20.
- Xu X.H., Shah P.K., Faure E. et al. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL // Circulation. -2001. V.104. — P.3103−3108.
- Yang G.Y., Gong C., Qin Z., et al. Inhibition of TNFalpha attenuates infarct volume and ICAM-1 expression in ischemic mouse brain. // Neuroreport. -1998 V. 9, № 9. — P. 2131−2134.
- Yang Y., Ma Y., Han W., et al. Age-related differences in postinfarct left ventricular rupture and remodeling. // Am J Physiol Heart Circ Physiol. -2008,-V. 294.-P. H1815-H1822.
- Yang Z., Zingarelli B., Szabo C. Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfiision injury. // Circulation. 2000. -V. 101.-P. 1019−1026.
- Yaoita H., Ogawa K., Maehara K. Attenuation of ischemia/reperfusion injury in rats by caspase inhibitor. // Circulation 1998. — V.97 — P.276−281.
- Yoon S.S., Zheng Z.J. Elevated total white blood cell count with high blood glucose is associated with poor outcome after ischemic stroke. // J Stroke Cerebrovasc Dis. 2005. — V. 14, № 2. — P. 88−93.
- Yuan J. Neuroprotective strategies targeting apoptotic and necrotic cell death for stroke. // Apoptosis. 2009. — V. 14, № 4. — P. 469−477.
- Zhan X., Kim C., Sharp F.R. Very brief focal ischemia simulating transient ischemic attacks (TIAs) can injure brain and induce Hsp70 protein. // Brain Res. 2008 — V. 1234. — P. 183−197.
- Zhang X., Xu Z., Zhou L., et al. Plasma levels of Hsp70 and anti-Hsp70 antibody predict risk of acute coronary syndrome. // Cell Stress Chaperones.- 2010. V. 15, № 5. — P. 675−686.
- Zhao L.R., Spellman S., Kim J., et al. Synthetic fibronectin peptide exerts neuroprotective effects on transient focal brain ischemia in rats. // Brain Res.- 2005. V. 23.-P. 1−8.
- Zheng Z., Kim J.Y., Ma H. Anti-inflammatory effects of the 70 kDa heat shock protein in experimental stroke. // J Cereb Blood Flow Metab. 2008.- V.28,№ l.-P. 53−63.
- Zhu J., Quyyumi A.A., Wu H., et al. Increased serum levels of heat shock protein 70 are associated with low risk of coronary artery disease. // Arterioscler Thromb Vase Biol. 2003. — V. 23. — P. 1055−1059.
- Ziegler G., Harhausen D., Schepers C., et al. TLR2 has a detrimental role in mouse transient focal cerebral ischemia. // Biochemical and Biophysical Research Communications. 2007. — V. 359. — P. 574−579.
- Zymek P., Nah D. Y, Bujak M., et al. Interleukin-10 is not a critical regulator of infarct healing and left ventricular remodeling. // Cardiovascular Research. 2007. — V. 74, № 2.-P. 313−322.